Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Rheumatology (Oxford, England)|June 22, 2017
Janus kinase inhibitors clear to landMartin Aringer
Arthritis Research & Therapy|May 15, 2012
Vaccination under TNF blockade - less effective, but worthwhileMartin Aringer
Zeitschrift Fur Rheumatologie|July 17, 2025
[Dealing with antibodies against dsDNA or nucleosomes under anti-TNF treatment]Martin Aringer
Die Heilberufe|May 28, 2020
Martin Aringer
Acta Medica Austriaca|July 21, 2004
Periodic fever syndromes--a clinical overviewMartin Aringer
Wiener Medizinische Wochenschrift (1946)|April 23, 2003
[Cyclooxygenase 2 selective antirheumatic analgesics]Martin Aringer
Seminars in Arthritis and Rheumatism|November 30, 2019
EULAR/ACR classification criteria for SLEMartin Aringer
The Lancet. Rheumatology|June 2, 2021
Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2Martin Aringer
The Lancet. Rheumatology|February 8, 2026
Rapid remission and effect on organ manifestations with anifrolumabMartin Aringer
Journal of Autoimmunity|December 9, 2019
Inflammatory markers in systemic lupus erythematosusMartin Aringer
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|June 22, 2017
Janus kinase inhibitors clear to landMartin Aringer
Arthritis Research & Therapy|May 15, 2012
Vaccination under TNF blockade - less effective, but worthwhileMartin Aringer
Zeitschrift Fur Rheumatologie|July 17, 2025
[Dealing with antibodies against dsDNA or nucleosomes under anti-TNF treatment]Martin Aringer
Die Heilberufe|May 28, 2020
Martin Aringer
Acta Medica Austriaca|July 21, 2004
Periodic fever syndromes--a clinical overviewMartin Aringer
Wiener Medizinische Wochenschrift (1946)|April 23, 2003
[Cyclooxygenase 2 selective antirheumatic analgesics]Martin Aringer
Seminars in Arthritis and Rheumatism|November 30, 2019
EULAR/ACR classification criteria for SLEMartin Aringer
The Lancet. Rheumatology|June 2, 2021
Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2Martin Aringer
The Lancet. Rheumatology|February 8, 2026
Rapid remission and effect on organ manifestations with anifrolumabMartin Aringer
Journal of Autoimmunity|December 9, 2019
Inflammatory markers in systemic lupus erythematosusMartin Aringer
Pageof 22